Core Insights - Apollo Biowellness, Inc. has completed the first step in the merger process with Revive Regenerative, Inc., securing an initial capital tranche of $500,000 and finalizing an additional $3,000,000 with GSS Capital [1][3] - The integration of the Evolutionary Biologics brand into Revive Regenerative's sales and marketing team has been completed, and the company is nearing the completion of due diligence and consolidation audit processes [1] - The CEO expressed optimism about closing the transaction and aims to elevate the combined company to NASDAQ by the end of 2026 [3] Company Overview - Apollo Biowellness, Inc. and its subsidiary, Evolutionary Biologics, Inc., focus on the discovery, development, and marketing of products aimed at improving human health, positioning themselves as leaders in Regenerative Medicine [4] - The company is currently marketing licensed patent-pending natural stem cell mobilizing agents and a dual acting all-natural diet aid designed to help control hunger [4]